BACK TO NEWS
Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts human lifespan limit
Partnership Release
Event
News
Publication
May 25, 2021

Nature Communications

We investigated the dynamic properties of the organism state fluctuations along individual aging trajectories in a large longitudinal database of CBC measurements from a consumer diagnostics laboratory. To simplify the analysis, we used a log-linear mortality estimate from the CBC variables as a single quantitative measure of the aging process, henceforth referred to as dynamic organism state indicator (DOSI). We observed, that the age-dependent population DOSI distribution broadening could be explained by a progressive loss of physiological resilience measured by the DOSI auto-correlation time. Extrapolation of this trend suggested that DOSI recovery time and variance would simultaneously diverge at a critical point of 120 − 150 years of age corresponding to a complete loss of resilience. The observation was immediately confirmed by the independent analysis of correlation properties of intraday physical activity levels fluctuations collected by wearable devices. We conclude that the criticality resulting in the end of life is an intrinsic biological property of an organism that is independent of stress factors and signifies a fundamental or absolute limit of human lifespan.

T. Pyrkov, K. Avchaciov, A. Tarkhov, L. Menshikov, A. Gudkov, P. Fedichev

Read the article here

LINK TO ARTICLE
RECENT NEWS
News
Press Release
News
News
Peter Fedichev Named Among Business Insider's Rising Stars in Longevity
April 27, 2026
News
Press Release
News
News
Peter Fedichev on The Sheekey Science Show: Treating Aging as a Physics Problem
April 10, 2026
Event
Press Release
Event
News
Gero at Davos: Speaking on Aging Biology and AI-Driven Drug Discovery During World Economic Forum Week
January 19, 2026
Event
Press Release
Event
News
Peter Fedichev Presents "Longevity: The Next Drug Category After GLP-1. From Breakthrough Science to Aging Drugs" During JPM Healthcare Week
January 14, 2026